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Abstract
We investigated the contribution of the Na+/L-carnitine cotransporter in the transport of tetraethylammonium (TEA) by rat renal brush-border
membrane vesicles. The transient uphill transport of L-carnitine was observed in the presence of a Na+ gradient. The uptake of L-carnitine was of
high affinity (Km= 21 AM) and pH dependent. Various compounds such as TEA, cephaloridine, and p-chloromercuribenzene sulfonate
(PCMBS) had potent inhibitory effects for L-carnitine uptake. Therefore, we confirmed the Na+/L-carnitine cotransport activity in rat renal
brush-border membranes. Levofloxacin and PCMBS showed different inhibitory effects for TEA and L-carnitine uptake. The presence of an
outward H+ gradient induced a marked stimulation of TEA uptake, whereas it induced no stimulation of L-carnitine uptake. Furthermore,
unlabeled TEA preloaded in the vesicles markedly enhanced [14C]TEA uptake, but unlabeled L-carnitine did not stimulate [14C]TEA uptake.
These results suggest that transport of TEA across brush-border membranes is independent of the Na+/L-carnitine cotransport activity, and
organic cation secretion across brush-border membranes is predominantly mediated by the H+/organic cation antiporter.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Organic cations are actively secreted by the renal proximal
tubules [1]. In general, transport of organic cations in baso-
lateral membranes is facilitated by the transmembrane elec-
trical potential differences, whereas transport of organic
cations in the brush-border membrane is mediated by the
electroneutral H+/organic cation antiporter energized by the
transmembrane H+ gradient [2]. The H+/organic cation anti-
porter mediates the translocation of various cationic com-
pounds such as tetraethylammonium (TEA) [3,4], cimetidine
[5], procainamide [6], neurotoxin 1-methyl-4-phenylpyridi-
nium (MPP) [7] and amino-h-lactam antibiotics [8].
L-Carnitine plays an important role in h-oxidation of long-
chain fatty acids [9]. It is usually biosynthesized in some
tissues or absorbed from the diet. In the kidney, a high-affinity
Na+/L-carnitine cotransporter expressed in brush-border
membranes of proximal tubule cells mediates efficient reab-
sorption of filtrated L-carnitine (>90%). Thus, the Na+/L-
carnitine cotransporter contributes essentially to maintain the
serum level of L-carnitine in circulation [10,11]. Recently,
Tamai et al. [12] and Wu et al. [13] identified hOCTN2 as a
homolog of hOCTN1 from the human kidney and placenta,
respectively. hOCTN2mediates the high-affinity uptake of L-
carnitine in a Na+-dependent manner [12]. The physiological
function of hOCTN2 is suggested to be a high-affinity Na+/L-
carnitine cotransporter in various tissues including the kid-
ney, heart, skeletal muscle, and placenta. Especially in the
kidney, hOCTN2 is the key for retaining the serum carnitine
concentration. Nezu et al. [14], Tang et al. [15], and Wang et
al. [16] reported that themutations in the hOCTN2 gene cause
primary systemic carnitine deficiency, which is characterized
by low serum and intracellular concentrations of carnitine.
Interestingly, OCTN2 is a Na+-independent organic cation
transporter in addition to being a Na+-dependent carnitine
transporter [17]. Cationic compounds such as TEA, verapa-
mil, and pyrilamine are transported by hOCTN2 in a Na+-
independent manner [18]. Ohashi et al. [19] suggested that
OCTN2 might contribute to secretion of the organic cation
TEA in the renal apical membrane by comparing the dispo-
sition of kidney in wild-type and juvenile visceral steatosis
(jvs) mice, which are animal model for systemic carnitine
deficiency with mutation of OCTN2. However, the physio-
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logical role of organic cation secretion by OCTN2 in renal
brush-border membranes remains to be clarified.
We recently reported that the Na+/L-carnitine cotransporter
is expressed in the apical membranes of LLC-PK1 cells, the
pig kidney epithelial cell line which has been used exten-
sively as a model for the analysis of epithelial functions in
renal proximal tubules [20]. The carnitine uptake activity in
the apical membrane of LLC-PK1 cells is functionally similar
to OCTN2, a high-affinity Na+/L-carnitine cotransporter.
However, under the conditions in which Na+/L-carnitine
cotransport activity was saturated by adding 100 AM L-
carnitine to the apical side medium, the basolateral-to-apical
transcellular transport of [14C]TEA was unaffected [20].
These findings suggest that the L-carnitine transport system
in the apical membrane of LLC-PK1 cells is not responsible
for the efflux of TEA from the cells. Furthermore, the L-
carnitine transport system appeared to be distinct from the
H+/organic cation antiporter, which predominantly mediates
the secretion of organic cations [20].
In the present study, to examine whether the H+/organic
cation antiporter or the Na+/L-carnitine cotransporter medi-
ates predominant secretion of cationic drugs in the renal
brush-border membranes, we studied in detail the transport
characteristics of L-carnitine and TEA by rat renal brush-
border membrane vesicles. The present results suggest that
the H+/organic cation antiporter has distinct characteristics
from the Na+/L-carnitine cotransporter, and that principal
secretion of cationic drugs in the renal brush-border mem-
brane is mediated by the H+/organic cation antiporter.
2. Materials and methods
2.1. Materials
Cephalexin, cephaloridine (Shionogi Co., Osaka, Japan)
and levofloxacin (Daiichi Seiyaku Co., Tokyo, Japan) were
from the respective suppliers. L-[Methyl-3H]carnitine hydro-
chloride (3.11 TBq/mmol) was purchased from Amersham
International (Buckinghamshire, England). [1-14C]Tetraethy-
lammonium bromide was purchased from Du Pont-New
England Nuclear Research Products (Boston, MA). Tetrae-
thylammonium bromide, L-carnitine hydrochloride, cimeti-
dine, and nicotine tartrate dihydrate were purchased from
Nacalai Tesque (Kyoto, Japan). 1-Methyl-4-phenylpyridi-
nium iodide was purchased from Research Biochemicals
Incorporated (Natick, MA). p-Chloromercuribenzene sulfo-
nate (PCMBS) was purchased from Sigma Chemical (St.
Louis, MO). Diphenhydramine hydrochloride was purchased
from Tokyo Kasei Kogyo Co. (Tokyo, Japan). All other
chemicals were of the highest purity available.
2.2. Preparation of brush-border membrane vesicles
The brush-border membrane vesicles were isolated from
the renal cortex of male Wistar rats (200–240 g) by the Mg2 +
precipitation method as described previously [21]. The iso-
lated membrane vesicles were suspended in an experimental
buffer to give a final protein concentration of 10 mg/ml. In
general, the experimental buffer consisted of either 100 mM
mannitol, 100 mM potassium chloride or sodium chloride,
and 10 mM HEPES (pH 7.5) or 100 mM mannitol, 100 mM
potassium chloride or sodium chloride, and 10 mMMES (pH
6.0), and pH was adjusted with KOH or NaOH.
2.3. Uptake studies
The uptake of L-[3H]carnitine and [14C]TEA by brush-
border membrane vesicles was measured by rapid filtration
technique. Usually, membrane vesicles suspended in an
appropriate buffer were preincubated for 10 min at 25 jC
before the initiation of uptake. For the measurement of the
trans-stimulation effect, the vesicles were preincubated for 60
min at room temperature to equilibrate the vesicles with a
compound to be tested. In general, the uptake was initiated by
the addition of 80 Al of a buffer containing 125 nM L-
[3H]carnitine (final 100 nM) or 1 AM [14C]TEA (final 0.8
AM) to 20 Al of membrane suspension at 25 jC. At the
specified periods, the incubation was terminated by diluting
the reaction mixture with 1 ml of ice-cold stop solution
containing 150 mM NaCl and 20 mM HEPES/Tris (pH
7.5). The mixture was poured immediately onto Millipore
filters (HAWP, 0.45 Am, 2.5 cm diameter), and the filters were
washed once with 5 ml of ice-cold stop solution. In separate
experiments, the nonspecific association of the ligand with
vesicles was estimated by the addition of substrate mixture to
1 ml of ice-cold stop solution containing 20 Al of membrane
vesicles. This value was subtracted from the uptake data to
evaluate the specific uptake of the ligand. The radioactivity of
L-[3H]carnitine and [14C]TEA trapped in membrane vesicles
was determined in ACS II (Amersham International, Buck-
inghamshire, UK) by liquid scintillation counting. The pro-
tein content was determined by the method of Bradford [22],
using a protein assay kit (Bio-Rad, Richmond, CA) with
bovine g-globulin as the standard.
2.4. Statistical analysis
The statistical significance of differences between mean
values was calculated using the non-paired t test. Multiple
comparisons were performed using Scheffe´’s test.
3. Results
3.1. Characteristics of L-carnitine uptake by rat renal
brush-border membrane vesicles
First, we examined the effect of Na+ gradient on L-
carnitine uptake. The initial rate of L-carnitine uptake was
markedly stimulated in the presence of a Na+ gradient
compared with that in the absence of a Na+ gradient,
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showing transient uphill transport (overshoot phenom-
enon).
The concentration dependence of L-carnitine uptake by
rat renal brush-border membrane vesicles was also exam-
ined. The specific uptake was calculated by subtracting the
nonspecific uptake from the total uptake. With the use of
nonlinear-least squares regression analysis, kinetic parame-
ters were calculated according to the Michaelis–Menten
equation. The apparent Michaelis–Menten constant (Km)
value and maximal uptake rate (Vmax) value for L-carnitine
uptake were 21 AM and 22 pmol/mg protein/15 s, respec-
tively.
Fig. 1 illustrates the pH dependence of L-carnitine
uptake. When the pH in the uptake buffer was acidic, L-
carnitine uptake was markedly decreased compared with
that at neutral or alkaline pH. However, the uptake at neutral
pH was comparable with that at alkaline pH.
3.2. Inhibition of L-carnitine uptake by various compounds
The effects of various compounds on L-carnitine uptake
by rat renal brush-border membrane vesicles were exam-
Fig. 1. pH dependence of L-carnitine uptake by rat renal brush-border
membrane vesicles. Membrane vesicles (20 Al) suspended in 100 mM
mannitol, 100 mM KCl, and 10 mM HEPES (pH 7.5) were incubated at 25
jC for 30 s with the substrate mixture (80 Al) comprised of 100 mM
mannitol, 10 mM HEPES (pH 6.5–8.0) or MES (pH 5.5, 6.0), and 100 mM
NaCl in the presence (open symbols) or absence (closed symbols) of 1 mM
L-carnitine. Each point represents the meanF S.E. of three determinations.
Fig. 2. Effects of various compounds on L-carnitine uptake by rat renal
brush-border membrane vesicles. Membrane vesicles (20 Al) suspended in
100 mM mannitol, 100 mM KCl, and 10 mM HEPES (pH 7.5) were
incubated at 25 jC for 30 s with the substrate mixture (80 Al) comprised of
100 mM mannitol, 10 mM HEPES (pH 7.5), and 100 mM NaCl in the
presence of various compounds (1 mM). Each point represents the
meanF S.E. of three determinations.
Fig. 3. Effect of levofloxacin on TEA and L-carnitine uptake by rat renal
brush-border membrane vesicles. Membrane vesicles (20 Al) suspended in
100 mM mannitol, 100 mM KCl, and 10 mMMES (pH 6.0) or HEPES (pH
7.5) were incubated at 25 jC for 10 or 15 s with the substrate mixture (80
Al) comprised of 100 mM mannitol, 10 mM HEPES (pH 7.5), 100 mM KCl
or NaCl, and 1 AM [14C]TEA (closed symbols) or 125 nM L-[3H]carnitine
(open symbols) in the presence of various concentrations of levofloxacin.
Each point represents the meanF S.E. of three determinations.
Fig. 4. Effect of PCMBS on TEA and L-carnitine uptake by rat renal brush-
border membrane vesicles. Membrane vesicles (20 Al) suspended in 100
mM mannitol, 100 mM KCl, and 10 mMMES (pH 6.0) or HEPES (pH 7.5)
were incubated at 25 jC for 10 or 15 s with the substrate mixture (80 Al)
comprised of 100 mM mannitol, 10 mM HEPES (pH 7.5), 100 mM KCl or
NaCl, and 1 AM [14C]TEA (closed symbols) or 125 nM L-[3H]carnitine
(open symbols) in the presence of various concentrations of PCMBS. Each
point represents the meanF S.E. of three determinations.
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ined. As shown in Fig. 2, L-carnitine uptake was markedly
inhibited by TEA, cephaloridine, and PCMBS, whereas the
uptake was slightly inhibited by MPP, cimetidine, and
levofloxacin.
3.3. Inhibitions of TEA and L-carnitine uptake by
levofloxacin and PCMBS
We compared the effect of levofloxacin on TEA and L-
carnitine uptake. As shown in Fig. 3, levofloxacin inhibited
TEA uptake more strongly than L-carnitine uptake. The IC50
values of levofloxacin for TEA and L-carnitine uptake were
6 and 543 AM, respectively. Furthermore, Fig. 4 shows the
effect of PCMBS on TEA and L-carnitine uptake. PCMBS
potently inhibited both L-carnitine and TEA uptake. The
IC50 values of PCMBS for TEA and L-carnitine uptake were
4 and 30 AM, respectively.
3.4. Effect of H+ gradient on TEA and L-carnitine uptake
We examined the effect of an outward H+ gradient on TEA
and L-carnitine uptake. As shown in Fig. 5A and B, TEA
Fig. 6. Trans-stimulation effects of unlabeled TEA and L-carnitine on
[14C]TEA uptake by rat renal brush-border membrane vesicles. Membrane
vesicles were preincubated at room temperature for 1 h in 100 mM
mannitol, 100 mM NaCl, and 10 mM HEPES (pH 7.5) with each
concentration of unlabeled TEA (solid columns) or L-carnitine (hatched
columns) and then aliquots (20 Al) were incubated at 25 jC for 15 s with the
substrate mixture (180 Al) comprised of 100 mM mannitol, 10 mM HEPES
(pH 7.5), 100 mM NaCl, and 0.278 AM [14C]TEA. Control (open bar) were
shown as [14C]TEA uptake in the presence of extracellular unlabeled TEA
and L-carnitine (250 and 500 AM). Each column represents the mean F
S.E. of three determinations.
Fig. 5. Effect of H+ gradient on TEA (A) and L-carnitine (B) uptake by rat
renal brush-border membrane vesicles. Membrane vesicles (20 Al)
suspended in 100 mM mannitol, 100 mM KCl, and 10 mM MES (pH
6.0, closed symbols) or HEPES (pH 7.5, open symbols) were incubated at
25 jC for 10 s with the substrate mixture (80 Al) comprised of 100 mM
mannitol, 10 mM HEPES (pH 7.5), 100 mM KCl, and 1 AM [14C]TEA (A)
or 125 nM L-[3H]carnitine (B). Each point represents the meanF S.E. of
three determinations.
Fig. 7. Trans-stimulation effects of unlabeled TEA and L-carnitine on L-
[3H]carnitine uptake by rat renal brush-border membrane vesicles.
Membrane vesicles were preincubated at room temperature for 1 h in 100
mM mannitol, 100 mM NaCl, and 10 mM HEPES (pH 7.5) with each
concentration of unlabeled TEA (solid columns) or L-carnitine (hatched
columns) and then aliquots (20 Al) were incubated at 25 jC for 15 s with the
substrate mixture (180 Al) comprised of 100 mM mannitol, 10 mM HEPES
(pH 7.5), 100 mM NaCl, and 125 nM L-[3H]carnitine. Control (open bar)
were shown as L-[3H]carnitine uptake in the presence of extracellular
unlabeled TEA and L-carnitine (250 and 500 AM). Each column represents
the meanF S.E. of three determinations.
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uptake was markedly stimulated in the presence of a H+
gradient, showing transient uphill transport; on the other
hand, L-carnitine uptake was not. L-carnitine uptake increased
slightly in the presence of an outward H+ gradient (Fig. 5B).
3.5. Trans-stimulation effects on TEA and L-carnitine
uptake
Fig. 6 shows the trans-stimulation effects of unlabeled
TEA and L-carnitine on TEA uptake. The initial uptake rate
of [14C]TEA was markedly enhanced in the vesicles pre-
loaded with unlabeled TEA, but the uptake was not
enhanced by unlabeled L-carnitine. In addition, we exam-
ined the trans-stimulation effect of unlabeled TEA and L-
carnitine on L-[3H]carnitine uptake. As depicted in Fig. 7,
the uptake of L-[3H]carnitine was markedly stimulated in the
vesicles preloaded with unlabeled L-carnitine, whereas the
uptake was only slightly affected by unlabeled TEA.
4. Discussion
It was previously reported that the transport of organic
cations such as TEA and cimetidine in renal brush-border
membranes was mediated by the electroneutral H+/organic
cation antiporter energized by a transmembrane H+ gradient
[2]. Recently identified OCTN2 is not only a Na+-dependent
carnitine transporter but also a Na+-independent organic
cation transporter [17,19]. Therefore, to distinguish the H+/
organic cation antiporter from the Na+/L-carnitine cotrans-
porter on renal secretion of cationic drugs, the present study
examined the transport characteristics of L-carnitine and TEA
by rat renal brush-border membrane vesicles.
We here demonstrated that the Na+/L-carnitine cotran-
sport activity, which is similar to that of hOCTN2 in
transport characteristics, was expressed on rat renal brush-
border membranes. In the presence of a Na+ gradient, L-
carnitine uptake by the brush-border membranes was mark-
edly stimulated, showing a transient uphill transport and our
kinetic analysis suggested that L-carnitine uptake was high
affinity (Km= 21 AM) (data not shown). Furthermore, L-
carnitine uptake was dependent on the pH of the uptake
buffer with lowering uptake at acidic pH (Fig. 1). Tamai et
al. [12] demonstrated that hOCTN2 mediated Na+- and pH-
dependent L-carnitine transport with a Km value of 4.3 AM.
In addition, another uptake study using mouse renal brush-
border membrane vesicles showed a definite overshoot of
Na+- and concentration-dependent L-carnitine transport with
a Km value of 18.7 AM [23]. The present results appear to be
compatible with those, although the precise mechanisms of
pH dependence of the Na+/L-carnitine cotransporter still
remain to be clarified. The uptake of L-carnitine was not
stimulated in the presence of outward H+ gradient (Fig. 5B),
suggesting that the H+/L-carnitine exchange mechanism can
be most likely ruled out. Therefore, an allosteric regulation
of L-carnitine transport by protons might be involved in the
decreased uptake [24], because a charge of zwitterionic L-
carnitine (pKa = 3.7) was not changed in the present con-
dition (pH 5.5–8.0).
Ohashi et al. [18] reported that the L-carnitine uptake by
hOCTN2 was significantly inhibited by various cationic and
zwitterionic compounds. In the present study, the inhibitory
effects of various compounds on L-carnitine uptake were
comparable with those of Ohashi et al. [18] (Fig. 2). MPP,
cimetidine, and the quinolone antibacterial drug levoflox-
acin moderately inhibited L-carnitine uptake by the brush-
border membranes. In contrast, cephalexin showed no
inhibitory effect. It was also reported that all of these
cationic compounds strongly inhibit the H+/organic cation
antiporter in the renal brush-border membranes [5,8,25,26].
Accordingly, the present results suggest that the substrate
specificity of the Na+/L-carnitine cotransporter in rat renal
brush-border membranes is different from that of the H+/
organic cation antiporter.
Okano et al. [27] demonstrated that ofloxacin, an enan-
tiomer of levofloxacin, inhibits about 70% of TEA uptake in
rat renal brush-border membrane vesicles. Ohtomo et al.
[25] also reported that levofloxacin markedly inhibited the
apical H+/organic cation antiporter in LLC-PK1 cell mono-
layers. However, in the present study, 1 mM of levofloxacin
could only slightly inhibit the Na+/L-carnitine cotransporter
on rat renal brush-border membranes. Therefore, we com-
pared the affinity of levofloxacin on TEA and L-carnitine
uptake by the renal brush-border membrane vesicles. Levo-
floxacin inhibited TEA uptake more strongly than L-carni-
tine uptake (Fig. 3), suggesting that levofloxacin interacts
preferentially with the H+/organic cation antiporter rather
than the Na+/L-carnitine cotransporter. Furthermore, we
examined the effect of PCMBS on TEA and L-carnitine
uptake by the brush-border membranes. We previously
reported that PCMBS specifically inhibits the H+ gradient-
dependent transport of TEA in the renal brush-border
membranes [28] and LLC-PK1 cells [29]. In the present
study, PCMBS potently inhibited TEA as well as L-carnitine
(Fig. 4). Considering the membrane vesicles to be oriented
right-side-out, it is suggested that the functional sulfhydryl
groups of the H+/organic cation antiporter and the Na+/L-
carnitine cotransporter could be localized at the luminal
surface of the proximal tubule cells.
The uptake of [14C]TEA was stimulated in the presence
of an outward H+ gradient (Fig. 5A), in an agreement with
the previously reported transport mechanism of organic
cations [2], whereas the uptake of L-[3H]carnitine was not
stimulated in the presence of an outward H+ gradient (Fig.
5B), suggesting that H+ gradient is not the driving force for
L-carnitine uptake by the brush-border membranes. How-
ever, it is noteworthy that a slight increase in L-carnitine
uptake was observed in the presence of an H+ gradient (Fig.
5B). This finding suggests that L-carnitine might be partially
transported by the H+/organic cation antiporter. On the other
hand, this result could reflect a small inside negative
potential generated by an outwardly directed H+ gradient,
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because OCTN2-mediated L-carnitine transport is electro-
genic [11,24,30].
Trans-stimulation of [14C]TEA uptake by unlabeled TEA
was observed, whereas trans-stimulation by unlabeled L-
carnitine was not observed (Fig. 6). This result suggests the
predominant transport activity of TEA by the H+/organic
cation antiporter on rat renal brush-border membranes. We
also found that the uptake of [14C]TEA was stimulated by
unlabeled L-carnitine being preloaded into vesicles in the
presence of an outward Na+ gradient (data not shown). In
renal brush-border membranes, the H+ gradient could be
created by a Na+/H+ antiporter [31–33] Therefore, the
stimulative effect could be due to the two functionally linked
antiport system, the Na+/H+ antiporter and the H+/organic
cation antiporter. Furthermore, we examined the trans-stim-
ulation effects of L-carnitine uptake. The uptake of L-[3H]car-
nitine by the renal brush-border membranes was markedly
enhanced by unlabeled L-carnitine (Fig. 7). Interestingly, the
slight stimulation of L-[3H]carnitine uptake by unlabeled
TEA was observed (Fig. 7), suggesting that the Na+/L-
carnitine cotransporter might possibly have a functional
property similar to L-carnitine/organic cation exchanger par-
tially in the renal brush-border membranes. Ohashi et al. [19]
reported that jvs mice showed decreased renal secretory
clearance of TEA, and that mutual trans-effects of OCTN2-
mediated TEA and L-carnitine transport were observed in
OCTN2-expressing HEK293 cells. Concerning these find-
ings, they proposed that OCTN2 functions as an exchanger of
Na+-dependent L-carnitine reabsorption and Na+-independ-
ent secretion of organic cations in renal epithelial cells [19].
However, they also demonstrated that renal function (glo-
merular filtration and/or renal blood flow) in jvs mice may be
impaired due to sever cardiomyopathy [19]. Taking this
finding into consideration, it could be speculated that loss
of renal organic cations secretion in jvs mice might reflect not
only impairment of OCTN2 as organic cation transporter but
also that of other transporters containing H+/organic cation
antiporter. Therefore, the contribution of the Na+/L-carnitine
cotransporter to renal secretion of cationic drugs is not clear.
The Na+/L-carnitine cotransporter is expressed in ubiquitous
tissues including the kidney, heart, skeletal muscle, and
placenta. It should be further investigated whether the Na+/
L-carnitine cotransporter contributes to the disposition of
pharmacologically active cationic drugs in these tissues.
In conclusion, the present results suggest that principal
organic cation transport activity is independent of the Na+/L-
carnitine cotransporter in rat renal brush-border membranes,
and that the H+/organic cation antiporter plays a predom-
inant physiological role in organic cation secretion in the
proximal tubule cells.
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